Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer

Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer

This study aims to compare intravenous chemotherapy versus intraperitoneal chemotherapy in patients with recurrent ovarian cancer.

Inclusion Criteria:

• women who had recurrent ovarian cancer and was treated with either intravenous or intraperitoneal platinum based chemotherapy

Exclusion Criteria:

• women who did not complete the designated treatment course (exception to those who had to quit due to progressive disease or death of any cause)